<DOC>
	<DOC>NCT00559546</DOC>
	<brief_summary>The purpose of the study is to find out if montelukast can be used to treat the various symptoms of allergic syndrome.</brief_summary>
	<brief_title>Montelukast as a Controller of Atopic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Wheal diameter at least 4 mm in skinprick test for both birch and timothy Allergic symptoms in both upper airways (allergic rhinitis) and lower airways (asthmalike symptoms or diagnosed asthma) and at least one of the following: Allergic conjunctivitis Atopic eczema Oral symptoms from vegetables or fruits by cross reactivity to birch Urticaria in allergen exposure Need for regular treatment with glucocorticoids Current smoking Other major disease or need for regular drug treatment Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>